Deputy Director and Associate Director for Clinical Research

Robert Dreicer, MD, MS, MACP, FASCO

Email: [email protected]
Phone: 434.924.9333

Robert Dreicer, MD, MS, MACP, FASCO, is the deputy director of the UVA Comprehensive Cancer Center and associate director for clinical research. He provides administrative and scientific oversight of the Office for Clinical Research, Protocol Review Committee, and Data and Safety Monitoring Committee. He is also section head of solid tumor oncology in the School of Medicine’s Division of Hematology and Oncology, a professor of medicine and urology, and co-director of the Mellon Institute.

An internationally recognized medical oncologist, Dr. Dreicer researches novel therapeutic approaches for urologic cancer, including prostate, urothelial, and kidney cancers. He received his medical degree from the University of Texas-Houston and a master of science from the University of Texas Graduate School of Biomedical Sciences at Houston.

Following his oncology fellowship, Dr. Dreicer joined the faculty at the University of Iowa, achieving tenure and serving as the associate director of the Division of Hematology/Oncology. He was recruited to Cleveland Clinic, where he served as chair of the Department of Solid Tumor Oncology from 2006-2014 before joining UVA Health in 2015.

Dr. Dreicer previously served as co-chair of the National Cancer Institute Genitourinary Oncology Steering Committee and as a member of the Medical Oncology Longitudinal Test Assessment Committee of the American Board of Internal Medicine. He is a longstanding associate editor of New England Journal of Medicine Clinician.